ReviewBiomolecules2022
Keeping Cell Death Alive: An Introduction into the French Cell Death Research Network.
Open access · goldAbstract readReview
In one paragraph
Review in Biomolecules, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 48% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 3 citations in OpenAlex.
- Diagnostic role and immune correlates of programmed cell death-related genes in hepatocellular carcinoma.Scientific reports · 2023Article
- Effect of regulatory cell death on the occurrence and development of head and neck squamous cell carcinoma.Biomarker research · 2023Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
32 authors at 5 institutions in 2 countries.
Gabriel IchimCancer Cell Death Laboratory, Part of LabEx DEVweCAN, Cancer Initiation and Tumoral Cell Identity Department, CRCL, 69008 Lyon, France.ORCID 0000-0002-8386-7405
Benjamin GibertApoptosis, Cancer and Development Laboratory-Equipe Labellisée 'La Ligue', LabEx DEVweCAN, Centre de Recherche en Cancérologie de Lyon, INSERM U1052-CNRS UMR5286, Claude Bernard University Lyon 1, 69008 Lyon, France.ORCID 0000-0002-5295-3124
Sahil AdriouchINSERM U1234, Pathophysiology, Autoimmunity, and ImmunoTHERapies (PANTHER), Normandie University, UNIROUEN, 76000 Rouen, France.ORCID 0000-0002-0265-7773
Catherine BrennerCNRS, Institut Gustave Roussy, Aspects Métaboliques et Systémiques de L'oncogénèse pour de Nouvelles Approches Thérapeutiques, Université Paris-Saclay, 94805 Villejuif, France.ORCID 0000-0002-7715-0934
Nathalie DavoustLaboratory of Biology and Modelling of the Cell, Ecole Normale Superieure of Lyon, CNRS, UMR 5239, INSERM U1293, University Claude Bernard Lyon 1, 46 allee d'Italie, F-69364 Lyon, France.
Solange DesagherInstitut de Génétique Moléculaire de Montpellier, Université de Montpellier, CNRS, 34293 Montpellier, France.ORCID 0000-0002-3735-7527
David DevosINSERM UMR-S-U1172, Lille Neurosciences & Cognition, University of Lille, CHU Lille, F-59000 Lille, France.
Svetlana DokudovskayaCNRS, Institut Gustave Roussy, Aspects Métaboliques et Systémiques de L'oncogénèse pour de Nouvelles Approches Thérapeutiques, Université Paris-Saclay, 94805 Villejuif, France.
Laurence DubrezInstitut National de la Santé et de la Recherche Médicale (INSERM) INSERM LNC UMR1231, LabEx LipSTIC, 21000 Dijon, France.ORCID 0000-0002-7030-2181
Jérôme EstaquierINSERM U1124, Université Paris Cité, F-75006 Paris, France.
Germain GilletCentre de Recherche en Cancérologie de Lyon, U1052 INSERM, UMR CNRS 5286, Centre Léon Bérard, Université Lyon I, 28 Rue Laennec, 69008 Lyon, France.
Isabelle GuénalLGBC, UVSQ, Université Paris-Saclay, 78000 Versailles, France.ORCID 0000-0003-1186-1458
Philippe P JuinINSERM CRCI2 NA, Université de Nantes, F-44000 Nantes, France.
Guido KroemerInstitut Universitaire de France, Centre de Recherche des Cordeliers, Equipe Labellisée par la Ligue Contre le Cancer, Université de Paris, Sorbonne Université, INSERM U1138, 75006 Paris, France.ORCID 0000-0002-9334-4405
Patrick LegembreContrôle de la Réponse Immune B et Lymphoproliférations, CRIBL, Université Limoges, UMR CNRS 7276, INSERM 1262, 87025 Limoges, France.ORCID 0000-0001-6649-8049
Romain LevayerDepartment of Developmental and Stem Cell Biology, Institut Pasteur, Université de Paris Cité, CNRS UMR3738, F-75015 Paris, France.ORCID 0000-0001-6769-1465
Stéphen ManonUMR 5095, CNRS, Université de Bordeaux, 33000 Bordeaux, France.ORCID 0000-0002-5792-1084
Patrick MehlenApoptosis, Cancer and Development Laboratory-Equipe Labellisée 'La Ligue', LabEx DEVweCAN, Centre de Recherche en Cancérologie de Lyon, INSERM U1052-CNRS UMR5286, Claude Bernard University Lyon 1, 69008 Lyon, France.
Olivier MeuretteApoptosis, Cancer and Development Laboratory-Equipe Labellisée 'La Ligue', LabEx DEVweCAN, Centre de Recherche en Cancérologie de Lyon, INSERM U1052-CNRS UMR5286, Claude Bernard University Lyon 1, 69008 Lyon, France.
Olivier MicheauINSERM, Lipides Nutrition Cancer, UMR 1231, Université de Bourgogne Franche-Comté, 21000 Dijon, France.ORCID 0000-0001-8499-7984
Bernard MignotteLGBC, UVSQ, Université Paris-Saclay, 78000 Versailles, France.ORCID 0000-0002-8512-8518
Florence Nguyen-KhacCell Death and Drug Resistance in Hematological Disorders Team, Centre de Recherche des Cordeliers, UMRS 1138, INSERM, Sorbonne Université, F-75006 Paris, France.
Nikolay PopgeorgievCentre de Recherche en Cancérologie de Lyon, U1052 INSERM, UMR CNRS 5286, Centre Léon Bérard, Université Lyon I, 28 Rue Laennec, 69008 Lyon, France.
Jean-Luc PoyetINSERM, HIPI, Université Paris Cité, F-75475 Paris, France.ORCID 0000-0002-3747-255X
Muriel PriaultCNRS, IBGC, UMR 5095, University Bordeaux, F-33000 Bordeaux, France.ORCID 0000-0001-8193-0389
Jean-Ehrland RicciINSERM C3M, Equipe Labellisée LIGUE Contre le Cancer, Université Côte d'Azur, 06200 Nice, France.
Franck B RiquetCell Death and Inflammation Unit, VIB-UGent Center for Inflammation Research (IRC) & Department of Biomedical Molecular Biology (DBMB), Ghent University, B-9052 Ghent, Belgium.
Santos A SusinCell Death and Drug Resistance in Hematological Disorders Team, Centre de Recherche des Cordeliers, UMRS 1138, INSERM, Sorbonne Université, F-75006 Paris, France.ORCID 0000-0002-3366-1628
Magali SuzanneCentre de Biologie Intégrative, CNRS/UMR 5088, Université Toulouse III, 31062 Toulouse, France.ORCID 0000-0003-0801-3706
Pierre VacherINSERM U1218, Institut Bergonié, 33000 Bordeaux, France.ORCID 0000-0003-3503-7981
Ludivine WalterLaboratory of Biology and Modelling of the Cell, Ecole Normale Superieure of Lyon, CNRS, UMR 5239, INSERM U1293, University Claude Bernard Lyon 1, 46 allee d'Italie, F-69364 Lyon, France.
Bertrand MollereauLaboratory of Biology and Modelling of the Cell, Ecole Normale Superieure of Lyon, CNRS, UMR 5239, INSERM U1293, University Claude Bernard Lyon 1, 46 allee d'Italie, F-69364 Lyon, France.ORCID 0000-0003-4710-8185
Inserm · FRCentre National de la Recherche Scientifique · FRUniversité Claude Bernard Lyon 1 · FRÉcole Pratique des Hautes Études · FRCentre de Recherche en Cancérologie de Lyon · FR
Funding
No grant is acknowledged in the PubMed record.
Abstract
Since the Nobel Prize award more than twenty years ago for discovering the core apoptotic pathway in
Indexed as
Caenorhabditis elegansNeoplasmsAnimalsApoptosisCell DeathHumansNecrosisapoptosiscancercell deathnecrosis
Identifiers
What Socratic holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.